KUALA LUMPUR: Duopharma Biotech Bhd
’s expansion into the Indonesian market will enable the group to create a bigger global presence and seize exciting opportunities for collaboration that will in turn contribute to better healthcare outcomes.
In April 2023, the company established PT Duopharma Healthcare Indonesia (PT DHI) as a wholly-owned subsidiary of the company in Indonesia.
Already a subscriber? Log in
Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.
Cancel anytime. Ad-free. Unlimited access with perks.
